RT @UMCGlobalSafety: 💡We're pleased to launch a new #pharmacovigilance communications resource! The PV Cycle explores each stage of the medicines safety cycle via the eyes of a diabetic patient and highlights the importance of reporting side effects.

Follow Lisa's journey 👉 https://ow.ly/EoZ950LOJE4

🐦🔗: https://nitter.eu/EMA_News/status/1597553319400329216